GlassScriptPhysician profile
Jennifer Stanley
NPI 1487040283
$4,000.16
in general payments reported to CMS, 2019-2025
38 companies · $440 in 2025
The $440 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265 · 2020: $363 · 2021: $791 · 2022: $929 · 2023: $549 · 2024: $662 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,651.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $588.38 | 2019-2025 | |
| Daiichi Sankyo INC. | $403.34 | 2019-2025 | Injectafer |
| Therapeuticsmd, INC. | $308.58 | 2019-2022 | |
| Medtronic, INC. | $296.47 | 2022-2025 | V-Loc 180, Truclear |
| Astellas Pharma US INC | $228.09 | 2022-2025 | Veozah |
| Abbvie INC. | $225.76 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Exeltis, USA INC. | $182.96 | 2021-2025 | Slynd |
| Myovant Sciences INC. | $173.98 | 2021-2022 | |
| Integra Lifesciences Corporation | $150.50 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Novo Nordisk INC | $144.65 | 2024 | Wegovy |
| Organon LLC | $115.17 | 2021-2025 | Nexplanon |
| Baxter Healthcare | $107.24 | 2020 | |
| Pfizer INC. | $104.72 | 2021-2023 | |
| Hologic Sales and Service, LLC | $90.40 | 2022-2025 | Aptima, Affirm Prone Biopsy System |
| Pacira Pharmaceuticals Incorporated | $88.26 | 2021-2025 | Exparel |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $79.22 | 2021-2025 | Phexxi, Solosec, Phexx |
| Sumitomo Pharma America, INC. | $78.51 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $77.96 | 2021-2024 | |
| Scynexis, INC. | $61.61 | 2021-2022 | |
| Coopersurgical, INC. | $60.48 | 2020-2024 | Paragard T 380a |
| Avion Pharmaceuticals | $56.28 | 2019-2020 | |
| Lupin INC. | $49.16 | 2019-2020 | |
| Smith+Nephew, INC. | $48.35 | 2023 | Stravix Pl |
| Ethicon US, LLC | $47.68 | 2021-2025 | Ethicon, Dermabond Prineo, Stratafix |
| Merck Sharp & Dohme LLC | $26.23 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $25.58 | 2023 | Vivjoa |
| Alexion Pharmaceuticals, INC. | $22.99 | 2022 | |
| Abbott Laboratories | $21.82 | 2022 | |
| Aspira Women'S Health INC | $18.30 | 2022 | |
| Exact Sciences Corporation | $16.36 | 2025 | Cologuard Collection Kit |
| Dexcom, INC. | $16.35 | 2025 | Dexcom G6 Transmitter |
| Biotissue Holdings INC. | $14.99 | 2024 | |
| Medical Device Business Services, INC. | $14.30 | 2022 | |
| Amgen INC. | $13.40 | 2024 | Prolia, Evenity |
| Sage Therapeutics, LLC | $12.63 | 2020 | |
| Allergan, INC. | $12.50 | 2019 | |
| Convatec INC. | $12.30 | 2022 | |
| Meditrina | $4.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Stanley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.